US FDA

21 CFR 211.186 - Master Production and Control Records

Plain-language explanation, inspection context and common violation patterns.

What it says

To assure uniformity from batch to batch, master production and control records must be prepared for each drug product and batch size, dated and signed by one person, independently checked, dated and signed by a second person, and must include product identity, component lists, yield, manufacturing and control instructions, sampling and testing procedures and special notations.

Paraphrased for plain-language clarity. Always verify against the current published regulation text.

What it means in practice

What FDA inspectors look for

Most common violation

Batch production records issued from a master record that was changed without documented review or that does not match the approved version.

Related regulations

Want a deeper, interactive breakdown?

GMPify's Regulation Explainer tool gives subscribers an AI-powered analysis of any 21 CFR, EU GMP, USP or ICH reference, with live inspection context.

Try the Regulation Explainer →